{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T07:44:04Z","timestamp":1785915844012,"version":"3.56.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Open Access Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiac magnetic resonance (CMR) may provide insights into arrhythmogenic substrate in patients undergoing ventricular tachycardia (VT) ablation, but its prognostic value remains uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a systematic review and meta-analysis, following PRISMA guidelines, of available studies comparing CMR-derived parameters in patients with and without VT recurrence after ablation, from inception to March 2026. Primary outcomes included functional parameters - left ventricular ejection fraction (LVEF) and left ventricular (LV) mass, while secondary outcomes included ventricular volumes and late gadolinium enhancement (LGE) derived structural characteristics. Random-effects models were applied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Seven studies including 415 patients were analyzed, with 36.1% experiencing VT recurrence. Lower LVEF was associated with recurrence in the primary analysis (mean difference: \u2212\u20094.41%; 95% CI: \u2212\u20098.66 to \u2212\u20090.16;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.044; I\u00b2=27.3%), however, this finding was not robust in leave-one-out analysis. No significant associations were observed for LV mass or ventricular volumes. Among structural parameters, transmural, epicardial, or septal LGE were not associated with recurrence.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Available evidence suggests that CMR-derived parameters have limited and inconsistent associations with VT recurrence after catheter ablation. Although reduced LVEF may be associated with recurrence, this finding was not robust in sensitivity analyses, while structural CMR characteristics showed no consistent associations. Larger prospective studies using standardized CMR protocols and time-to-event analyses are needed to better define the prognostic role of CMR.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10840-026-02415-6","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:46:15Z","timestamp":1785912375000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiac magnetic resonance parameters and ventricular tachycardia recurrence after catheter ablation: a systematic review and meta-analysis"],"prefix":"10.1007","author":[{"given":"Alexandru","family":"Deaconu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"Abdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mircea Ioan Alexandru","family":"Bistriceanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Deaconu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Obaida","family":"Makdah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saif","family":"Almaghrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Matschuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosmin Gabriel","family":"Ursu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Onciul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radu Gabriel","family":"V\u0103t\u0103sescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"2415_CR1","doi-asserted-by":"publisher","unstructured":"Barsheshet A, Goldenberg I, Gelikas S, McNitt S, Polonsky B, Erez A et al. Competing risk of ventricular tachyarrhythmia and nonarrhythmic mortality in advanced heart failure. JACC Clin Electrophysiol 2026:S2405500X26002239. https:\/\/doi.org\/10.1016\/j.jacep.2026.02.028.","DOI":"10.1016\/j.jacep.2026.02.028"},{"key":"2415_CR2","doi-asserted-by":"publisher","first-page":"euaf272","DOI":"10.1093\/europace\/euaf272","volume":"28","author":"D Ranganathan","year":"2026","unstructured":"Ranganathan D, Mills MT, Ramalingam V, Vazquez-Calvo S, Quaiattini A, Joza J, et al. Heterogeneity of outcomes reporting in catheter ablation trials for ventricular tachycardia: a systematic review. EP Eur. 2026;28:euaf272. https:\/\/doi.org\/10.1093\/europace\/euaf272.","journal-title":"EP Eur"},{"key":"2415_CR3","doi-asserted-by":"publisher","first-page":"euaf302","DOI":"10.1093\/europace\/euaf302","volume":"27","author":"F Santoro","year":"2025","unstructured":"Santoro F, Mugnai G, Perrotta L, Kovacs B, Dinshaw L, del Castillo AM, et al. Catheter ablation vs. anti-arrhythmic drug therapy for ventricular tachycardia in ischaemic heart disease: a meta-analysis of randomized controlled trials. EP Eur. 2025;27:euaf302. https:\/\/doi.org\/10.1093\/europace\/euaf302.","journal-title":"EP Eur"},{"key":"2415_CR4","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/eurheartj\/ehq345","volume":"32","author":"AP Wijnmaalen","year":"2011","unstructured":"Wijnmaalen AP, Van Der Geest RJ, Van Huls CFB, Siebelink H-MJ, Kroft LJM, Bax JJ, et al. Head-to-head comparison of contrast-enhanced magnetic resonance imaging and electroanatomical voltage mapping to assess post-infarct scar characteristics in patients with ventricular tachycardias: real-time image integration and reversed registration. Eur Heart J. 2011;32:104\u201314. https:\/\/doi.org\/10.1093\/eurheartj\/ehq345.","journal-title":"Eur Heart J"},{"key":"2415_CR5","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1093\/eurheartj\/eht510","volume":"35","author":"D Andreu","year":"2014","unstructured":"Andreu D, Ortiz-P\u00e9rez JT, Boussy T, Fern\u00e1ndez-Armenta J, De Caralt TM, Perea RJ, et al. Usefulness of contrast-enhanced cardiac magnetic resonance in identifying the ventricular arrhythmia substrate and the approach needed for ablation. Eur Heart J. 2014;35:1316\u201326. https:\/\/doi.org\/10.1093\/eurheartj\/eht510.","journal-title":"Eur Heart J"},{"key":"2415_CR6","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s12471-020-01485-z","volume":"28","author":"AA Hendriks","year":"2020","unstructured":"Hendriks AA, Kis Z, Glisic M, Bramer WM, Szili-Torok T. Pre-procedural image-guided versus non-image-guided ventricular tachycardia ablation\u2014a review. Neth Heart J. 2020;28:573\u201383. https:\/\/doi.org\/10.1007\/s12471-020-01485-z.","journal-title":"Neth Heart J"},{"key":"2415_CR7","doi-asserted-by":"publisher","first-page":"18722","DOI":"10.1038\/s41598-021-97399-w","volume":"11","author":"S Merino-Caviedes","year":"2021","unstructured":"Merino-Caviedes S, Gutierrez LK, Alfonso-Almaz\u00e1n JM, Sanz-Est\u00e9banez S, Cordero-Grande L, Quintanilla JG, et al. Time-efficient three-dimensional transmural scar assessment provides relevant substrate characterization for ventricular tachycardia features and long-term recurrences in ischemic cardiomyopathy. Sci Rep. 2021;11:18722. https:\/\/doi.org\/10.1038\/s41598-021-97399-w.","journal-title":"Sci Rep"},{"key":"2415_CR8","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.jacep.2019.11.004","volume":"6","author":"D Soto-Iglesias","year":"2020","unstructured":"Soto-Iglesias D, Penela D, J\u00e1uregui B, Acosta J, Fern\u00e1ndez-Armenta J, Linhart M, et al. Cardiac Magnetic Resonance-Guided Ventricular Tachycardia Substrate Ablation. JACC Clin Electrophysiol. 2020;6:436\u201347. https:\/\/doi.org\/10.1016\/j.jacep.2019.11.004.","journal-title":"JACC Clin Electrophysiol"},{"key":"2415_CR9","doi-asserted-by":"publisher","first-page":"euae108","DOI":"10.1093\/europace\/euae108","volume":"26","author":"T Deneke","year":"2024","unstructured":"Deneke T, Kutyifa V, Hindricks G, Sommer P, Zeppenfeld K, Carbucicchio C, et al. Pre- and post-procedural cardiac imaging (computed tomography and magnetic resonance imaging) in electrophysiology: a clinical consensus statement of the European Heart Rhythm Association and European Association of Cardiovascular Imaging of the European Society of Cardiology. Europace. 2024;26:euae108. https:\/\/doi.org\/10.1093\/europace\/euae108.","journal-title":"Europace"},{"key":"2415_CR10","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.hrthm.2022.06.006","volume":"19","author":"Y Ishidoya","year":"2022","unstructured":"Ishidoya Y, Ranjan R. Using MRI to predict ventricular tachycardia recurrence and provide guidance for ablation? Heart Rhythm. 2022;19:1611\u20132. https:\/\/doi.org\/10.1016\/j.hrthm.2022.06.006.","journal-title":"Heart Rhythm"},{"key":"2415_CR11","doi-asserted-by":"publisher","first-page":"euaf244","DOI":"10.1093\/europace\/euaf244","volume":"27","author":"JB Tonko","year":"2025","unstructured":"Tonko JB, Cabrera-Borrego E, S\u00e1nchez-Mill\u00e1n P, Jim\u00e9nez-J\u00e1imez J, Chow A, Lambiase PD. Effect of scar distribution on transmural and planar repolarization gradients and dispersion in non-ischemic cardiomyopathies with ventricular arrhythmias. EP Eur. 2025;27:euaf244. https:\/\/doi.org\/10.1093\/europace\/euaf244.","journal-title":"EP Eur"},{"key":"2415_CR12","doi-asserted-by":"publisher","unstructured":"De Marco C, Asatryan B, Te Riele ASJM, Di Marco A, Gasperetti A, Delini\u00e8re A, et al. Left ventricular late gadolinium enhancement for arrhythmic risk prediction in ARVC. Circ Arrhythm Electrophysiol. 2026;19. https:\/\/doi.org\/10.1161\/CIRCEP.125.014265.","DOI":"10.1161\/CIRCEP.125.014265"},{"key":"2415_CR13","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/europace\/euab127","volume":"23","author":"L Quinto","year":"2021","unstructured":"Quinto L, Sanchez P, Alarc\u00f3n F, Garre P, Zaraket F, Prat-Gonzalez S, et al. Cardiac magnetic resonance to predict recurrences after ventricular tachycardia ablation: septal involvement, transmural channels, and left ventricular mass. EP Eur. 2021;23:1437\u201345. https:\/\/doi.org\/10.1093\/europace\/euab127.","journal-title":"EP Eur"},{"key":"2415_CR14","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.hrthm.2022.05.021","volume":"19","author":"P Bhagirath","year":"2022","unstructured":"Bhagirath P, Campos FO, Costa CM, Wilde AAM, Prassl AJ, Neic A, et al. Predicting arrhythmia recurrence following catheter ablation for ventricular tachycardia using late gadolinium enhancement magnetic resonance imaging: Implications of varying scar ranges. Heart Rhythm. 2022;19:1604\u201310. https:\/\/doi.org\/10.1016\/j.hrthm.2022.05.021.","journal-title":"Heart Rhythm"},{"key":"2415_CR15","doi-asserted-by":"publisher","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;n71. https:\/\/doi.org\/10.1136\/bmj.n71.","DOI":"10.1136\/bmj.n71"},{"key":"2415_CR16","doi-asserted-by":"publisher","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;i4919. https:\/\/doi.org\/10.1136\/bmj.i4919.","DOI":"10.1136\/bmj.i4919"},{"key":"2415_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14:135. https:\/\/doi.org\/10.1186\/1471-2288-14-135.","journal-title":"BMC Med Res Methodol"},{"key":"2415_CR18","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jacep.2015.07.006","volume":"1","author":"P \u00c1vila","year":"2015","unstructured":"\u00c1vila P, P\u00e9rez-David E, Izquierdo M, Rojas-Gonz\u00e1lez A, S\u00e1nchez-G\u00f3mez JM, Ledesma-Carbayo MJ, et al. Scar Extension Measured by Magnetic Resonance\u2013Based Signal Intensity Mapping Predicts Ventricular Tachycardia Recurrence After Substrate Ablation in Patients With Previous Myocardial Infarction. JACC Clin Electrophysiol. 2015;1:353\u201365. https:\/\/doi.org\/10.1016\/j.jacep.2015.07.006.","journal-title":"JACC Clin Electrophysiol"},{"key":"2415_CR19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/jce.12848","volume":"27","author":"M Njeim","year":"2016","unstructured":"Njeim M, Yokokawa M, Frank L, Crawford T, Good E, Morady F, et al. Value of Cardiac Magnetic Resonance Imaging in Patients With Failed Ablation Procedures for Ventricular Tachycardia. J Cardiovasc Electrophysiol. 2016;27:183\u20139. https:\/\/doi.org\/10.1111\/jce.12848.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2415_CR20","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s10840-025-02017-8","volume":"68","author":"S Oebel","year":"2025","unstructured":"Oebel S, Garcia Garcia J, Arya A, Jahnke C, Paetsch I, L\u00f6be S, et al. Late gadolinium enhancement imaging for the prediction of ventricular tachycardia ablation outcome. J Interv Card Electrophysiol. 2025;68:1075\u201385. https:\/\/doi.org\/10.1007\/s10840-025-02017-8.","journal-title":"J Interv Card Electrophysiol"},{"key":"2415_CR21","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/ehjci\/jead261","volume":"25","author":"I Roca-Luque","year":"2024","unstructured":"Roca-Luque I, V\u00e1zquez-Calvo S, Garre P, Ortiz-Perez JT, Prat-Gonzalez S, Sanchez-Somonte P, et al. Post-Ablation cardiac Magnetic resonance to assess Ventricular Tachycardia recurrence (PAM-VT study). Eur Heart J - Cardiovasc Imaging. 2024;25:188\u201398. https:\/\/doi.org\/10.1093\/ehjci\/jead261.","journal-title":"Eur Heart J - Cardiovasc Imaging"},{"key":"2415_CR22","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1093\/europace\/euz127","volume":"21","author":"F Torri","year":"2019","unstructured":"Torri F, Czimbalmos C, Bertagnolli L, Oebel S, Bollmann A, Paetsch I, et al. Agreement between gadolinium-enhanced cardiac magnetic resonance and electro-anatomical maps in patients with non-ischaemic dilated cardiomyopathy and ventricular arrhythmias. EP Eur. 2019;21:1392\u20139. https:\/\/doi.org\/10.1093\/europace\/euz127.","journal-title":"EP Eur"},{"key":"2415_CR23","doi-asserted-by":"publisher","unstructured":"Berruezo A, Falasconi G, Penela D. Ventricular tachycardia functional substrate targeting: a standalone strategy for all? Europace. 2025;27(euaf004). https:\/\/doi.org\/10.1093\/europace\/euaf004.","DOI":"10.1093\/europace\/euaf004"},{"key":"2415_CR24","doi-asserted-by":"publisher","unstructured":"Carta-Bergaz A, R\u00edos-Mu\u00f1oz GR, Cris\u00f3stomo V, B\u00e1ez C, Blanco V, S\u00e1nchez-Margallo FM, et al. Scar voltage mapping in fast ventricular tachycardia for identifying functional substrates of tachycardia isthmuses: a proof-of-concept study. Circ Arrhythm Electrophysiol. 2025;18. https:\/\/doi.org\/10.1161\/CIRCEP.125.013793.","DOI":"10.1161\/CIRCEP.125.013793"},{"key":"2415_CR25","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.jacep.2015.09.002","volume":"1","author":"TM Dickfeld","year":"2015","unstructured":"Dickfeld TM, Jimenez A. Prognostic Value of Scar Imaging for Substrate Ablation of Ventricular Tachycardia. JACC Clin Electrophysiol. 2015;1:366\u20138. https:\/\/doi.org\/10.1016\/j.jacep.2015.09.002.","journal-title":"JACC Clin Electrophysiol"},{"key":"2415_CR26","doi-asserted-by":"publisher","first-page":"e012482","DOI":"10.1161\/JAHA.119.012482","volume":"8","author":"G Cheniti","year":"2019","unstructured":"Cheniti G, Sridi S, Sacher F, Chaumeil A, Pillois X, Takigawa M, et al. Post\u2013Myocardial Infarction Scar With Fat Deposition Shows Specific Electrophysiological Properties and Worse Outcome After Ventricular Tachycardia Ablation. J Am Heart Assoc. 2019;8:e012482. https:\/\/doi.org\/10.1161\/JAHA.119.012482.","journal-title":"J Am Heart Assoc"},{"key":"2415_CR27","doi-asserted-by":"publisher","unstructured":"Casella M, D\u2019Angelo L, Narducci ML, Compagnucci P, Volpato G, Valeri Y et al. Comparing high-density electroanatomic mapping and MRI. JACC Clin Electrophysiol 2026:S2405500X26001295. https:\/\/doi.org\/10.1016\/j.jacep.2026.01.054.","DOI":"10.1016\/j.jacep.2026.01.054"},{"key":"2415_CR28","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1016\/j.hrthm.2025.11.008","volume":"23","author":"S V\u00e1zquez-Calvo","year":"2026","unstructured":"V\u00e1zquez-Calvo S, Eulogio-Valenzuela F, Falzone PV, Garre P, Althoff T, Guichard J-B, et al. Cardiac magnetic resonance to evaluate 3-dimensional ventricular substrate depth: Prognostic implications for ventricular tachycardia ablation approach. Heart Rhythm. 2026;23:e142\u201352. https:\/\/doi.org\/10.1016\/j.hrthm.2025.11.008.","journal-title":"Heart Rhythm"},{"key":"2415_CR29","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/jce.12963","volume":"27","author":"S Yamashita","year":"2016","unstructured":"Yamashita S, Sacher F, Mahida S, Berte B, Lim HS, Komatsu Y, et al. Image Integration to Guide Catheter Ablation in Scar-Related Ventricular Tachycardia. J Cardiovasc Electrophysiol. 2016;27:699\u2013708. https:\/\/doi.org\/10.1111\/jce.12963.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2415_CR30","doi-asserted-by":"publisher","first-page":"e13205","DOI":"10.1002\/joa3.13205","volume":"41","author":"A Nunes-Ferreira","year":"2025","unstructured":"Nunes-Ferreira A, Brito J, Cortez\u2010Dias N, Da Silva DL, Pinto G, De Sousa FJ. Preprocedural imaging guiding ventricular tachycardia ablation in structural heart disease. J Arrhythmia. 2025;41:e13205. https:\/\/doi.org\/10.1002\/joa3.13205.","journal-title":"J Arrhythmia"},{"key":"2415_CR31","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jcmg.2014.03.013","volume":"7","author":"SRD Piers","year":"2014","unstructured":"Piers SRD, Tao Q, De Riva Silva M, Siebelink H-M, Schalij MJ, Van Der Geest RJ, et al. CMR\u2013Based Identification of Critical Isthmus Sites of Ischemic and Nonischemic Ventricular Tachycardia. JACC Cardiovasc Imaging. 2014;7:774\u201384. https:\/\/doi.org\/10.1016\/j.jcmg.2014.03.013.","journal-title":"JACC Cardiovasc Imaging"},{"key":"2415_CR32","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.hrthm.2025.09.028","volume":"23","author":"D Laan","year":"2026","unstructured":"Laan D, Hopman LHGA, Figueras I, Ventura RM, Sor\u00e9 B, Allaart CP, Kemme MJB, et al. Ventricular tachycardia substrate mapping with cardiac computed tomography and cardiac magnetic resonance imaging: Head-to-head comparison of two clinically available postprocessing platforms. Heart Rhythm. 2026;23:721\u20139. https:\/\/doi.org\/10.1016\/j.hrthm.2025.09.028.","journal-title":"Heart Rhythm"},{"key":"2415_CR33","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.hroo.2024.07.001","volume":"5","author":"JC Burger","year":"2024","unstructured":"Burger JC, Hopman LHGA, Kemme MJB, Hoeksema W, Takx RAP, Figueras I, Ventura RM, et al. Optimizing ventricular tachycardia ablation through imaging-based assessment of arrhythmic substrate: A comprehensive review and roadmap for the future. Heart Rhythm O2. 2024;5:561\u201372. https:\/\/doi.org\/10.1016\/j.hroo.2024.07.001.","journal-title":"Heart Rhythm O2"},{"key":"2415_CR34","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.hrthm.2017.05.018","volume":"14","author":"D Andreu","year":"2017","unstructured":"Andreu D, Penela D, Acosta J, Fern\u00e1ndez-Armenta J, Perea RJ, Soto-Iglesias D, et al. Cardiac magnetic resonance\u2013aided scar dechanneling: Influence on acute and long-term outcomes. Heart Rhythm. 2017;14:1121\u20138. https:\/\/doi.org\/10.1016\/j.hrthm.2017.05.018.","journal-title":"Heart Rhythm"},{"key":"2415_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s10840-026-02336-4","author":"A Sanchez-Nadales","year":"2026","unstructured":"Sanchez-Nadales A, Amoateng R, Twing AH, Sanchez-Nadales A, Abdelhady K, Ringwala S, et al. Advancements in mapping, cardiac imaging, and ablation techniques for the management of ventricular tachycardias. J Interv Card Electrophysiol. 2026. https:\/\/doi.org\/10.1007\/s10840-026-02336-4.","journal-title":"J Interv Card Electrophysiol"},{"key":"2415_CR36","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1161\/CIRCULATIONAHA.125.074748","volume":"153","author":"I Roca-Luque","year":"2026","unstructured":"Roca-Luque I, Garre P, V\u00e1zquez-Calvo S, Ortiz-P\u00e9rez JT, Prat-Gonz\u00e1lez S, Perea RJ, et al. PAM-VT 2 Study: Long-Term Scar Evolution and Ablation Lesion Assessment by Late Gadolinium Enhancement Cardiac Magnetic Resonance After Ventricular Tachycardia Ablation. Circulation. 2026;153:874\u201386. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.125.074748.","journal-title":"Circulation"},{"key":"2415_CR37","doi-asserted-by":"publisher","first-page":"euaf071","DOI":"10.1093\/europace\/euaf071","volume":"27","author":"E Svennberg","year":"2025","unstructured":"Svennberg E, Han JK, Caiani EG, Engelhardt S, Ernst S, Friedman P, et al. State of the Art of Artificial Intelligence in Clinical Electrophysiology in 2025: A Scientific Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), and the ESC Working Group on E-Cardiology. EP Eur. 2025;27:euaf071. https:\/\/doi.org\/10.1093\/europace\/euaf071.","journal-title":"EP Eur"},{"key":"2415_CR38","doi-asserted-by":"publisher","unstructured":"Darma A, Waezsada S-E, Arya A, Khalaph M, Braun M, Fink T, et al. Determinants of recurrence after epicardial ventricular tachycardia ablation in structural heart disease. Heart Rhythm. 2026;S1547527126022769. https:\/\/doi.org\/10.1016\/j.hrthm.2026.04.026.","DOI":"10.1016\/j.hrthm.2026.04.026"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-026-02415-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-026-02415-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-026-02415-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:46:16Z","timestamp":1785912376000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10840-026-02415-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":38,"alternative-id":["2415"],"URL":"https:\/\/doi.org\/10.1007\/s10840-026-02415-6","relation":{},"ISSN":["1572-8595"],"issn-type":[{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"assertion":[{"value":"30 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval and informed consent were not required because this study is a systematic review and meta-analysis of previously published data and did not involve the collection of identifiable individual patient information.","order":1,"name":"Ethics","label":"Ethics statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors report no conflicts of interest. No relationship with the industry exists for any of the authors. All authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation.","order":2,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}